Victory Capital Management
EVLO

Victory Capital Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Victory Capital Management’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,893
Closed -$668K – 3485
2020
Q1 		$668K Buy
8,893
+4,298
+94% +$409K ﹤0.01% 1994
2019
Q4 		$373K Sell
4,595
-182
-4% -$20.4K ﹤0.01% 2131
2019
Q3 		$583K Buy
4,777
+1,576
+49% +$217K ﹤0.01% 1835
2019
Q2 		$575K Sell
3,201
-1,168
-27% -$189K ﹤0.01% 1357
2019
Q1 		$699K Sell
4,369
-44
-1% -$8.71K ﹤0.01% 1298
2018
Q4 		$1.15M Sell
4,413
-76
-2% -$15.3K ﹤0.01% 1182
2018
Q3 		$1.09M Sell
4,489
-244
-5% -$63.9K ﹤0.01% 1255
2018
Q2 		$1.12M Buy
+4,733
New +$1.38M ﹤0.01% 1229

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return